We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GLMD market cap is 570.02k. The company's latest EPS is USD -10.6345 and P/E is -0.03.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -5.38M | -2.45M | -2M | -1.87M | -1.47M |
Net Income | -5.35M | -2.64M | -1.83M | -1.59M | -1.47M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.04M | 0 | 0 | 0 | 0 |
Operating Income | -10.72M | -22.38M | -30.21M | -32.88M | -17.65M |
Net Income | -9.86M | -20.46M | -28.77M | -32.47M | -17.87M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 20.87M | 16.56M | 14.79M | 13.28M | 17.64M |
Total Liabilities | 5.12M | 3.14M | 2.8M | 2.72M | 2.09M |
Total Equity | 15.75M | 13.42M | 11.99M | 10.55M | 15.55M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 90.6M | 77.14M | 52.38M | 36.61M | 16.56M |
Total Liabilities | 2.71M | 7.29M | 8.23M | 6.11M | 3.14M |
Total Equity | 87.89M | 69.85M | 44.15M | 30.5M | 13.42M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.48M | -18.5M | -1.7M | -3.06M | -5.24M |
Investing | 15.58M | 17.56M | 1.35M | 2.06M | -1.48M |
Financing | 70k | 70k | N/A | N/A | 6.19M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.02M | -14.94M | -26.29M | -32.89M | -18.5M |
Investing | -60.02M | 6.68M | 16.54M | 11.46M | 17.56M |
Financing | 80.18M | 143k | 768k | 17.37M | 70k |
Market Cap | 570.02k |
Price to Earnings Ratio | -0.03 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.29 |
Price to Book Ratio | 0.04 |
Dividend Yield | - |
Shares Outstanding | 1.68M |
Average Volume (1 week) | 65.52k |
Average Volume (1 Month) | 240.02k |
52 Week Change | -94.74% |
52 Week High | 7.80 |
52 Week Low | 0.26 |
Spread (Intraday) | 0.01 (2.97%) |
Company Name | Galmed Pharmaceuticals Ltd |
Address |
16 tiomkin street tel aviv, center 6578317 |
Website | https://www.galmedpharma.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions